✦ LIBER ✦

EORTC-IDBBC (Investigational Drug Branch for Breast Cancer): Seven years of active European collaboration

✍ Scribed by A. Awada; T. Cufer; L. Beex; R. Coleman; R. Paridaens; P. Bruning; J. Klijn; M. Nooij; L. Mauriac; A. Van Vreckem; L. Biganzoli; M.J. Piccart

Book ID: 117666204
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 147 KB
Volume: 34
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(98)80083-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EORTC-IDBBC (Investigational Drug Branch

EORTC-IDBBC (Investigational Drug Branch For Breast Cancer): 5 Years of European collaboration in new drug development for breast cancer

✍ A Awada; A Van Vreckem; R Paridaens; P.F Bruning; J Klijn; E Tomiak; J Vinholes; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 374 KB

710 - Docetaxel (D) in combination with

710 - Docetaxel (D) in combination with amifostine (A) in metastatic breast cancer (MBC): A feasibility and pharmacoklnetlc study of the EORTC-investigational drug branch for breast cancer (IDBBC)

✍ A. Awada; D. de Valériola; N. Cornez; J. Kerger; A. Van Vreckem; S. Bartholomeus 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 216 KB

347 Steroids do reduce the severity and

347 Steroids do reduce the severity and delay the onset of docetaxel (DXT) induced fluid retention: Final results of a randomized trial of the EORTC investigational drug branch for breast cancer (IDBBC)

✍ M.J. Piccart; J. Klijn; R. Paridaens; M. Nooij; L. Mauriac; R. Coleman; A. Awada 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 126 KB